Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial
N
Shared by NobleBlocks on Sep 1, 2015 • 12:00 AM UTC
Authors:
Diamant Thaçi
,
Andrew Blauvelt
,
Kristian Reich
Research Assistant
AI chat, annotations, notes & similar papers
Finding related papers...
Discussions
(0)
No comments yet
Be the first to share your thoughts!
Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial | NobleBlocks
